Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia‐Pacific, sub‐Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration

Outreach
DOI: 10.7448/ias.17.1.19045 Publication Date: 2014-12-15T07:07:39Z
ABSTRACT
Introduction HIV care and treatment programmes worldwide are transforming as they push to deliver universal access essential prevention, services persons living with their communities. The characteristics capacity of these affect patient outcomes quality care. Despite the importance ensuring optimal outcomes, few studies have addressed comprehensive We sought describe such in seven regions worldwide. Methods Staff from 128 sites 41 countries participating International epidemiologic Databases Evaluate AIDS completed a site survey 2009 2010, including Asia‐Pacific region ( n= 20), Latin America Caribbean 7), North Central Africa 12), East 51), Southern 16) West 15). computed measure comprehensiveness based on World Health Organization‐recommended services. Results Most reported serving urban (61%; range (rr): 33–100%) both adult paediatric populations (77%; rr: 29–96%). Only 45% clinics that treating children had paediatricians staff. As for services, respondents CD4+ cell count testing was available all but one site, while tuberculosis (TB) screening community outreach were 80 72%, respectively. remaining four – nutritional support (82%), combination antiretroviral therapy adherence (88%), prevention mother‐to‐child transmission (PMTCT) (94%) other clinical management (97%) uniformly available. Approximately half (46%) offering Newer settings low rankings UN Human Development Index (HDI), especially those President's Emergency Plan Relief focus countries, tended offer more array programme varied according number years been operation HDI setting, recently established low‐HDI reporting Survey frequently identified contact tracing patients, outreach, counselling, onsite viral load testing, TB provision isoniazid preventive unavailable Conclusions This study serves baseline on‐going monitoring evolution delivery over time lays groundwork evaluating relation
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (46)